Insight

Adrienne Bruce Shannon: dMMR gastroesophageal cancer treated with immunotherapy

Photo taken from Adrienne Bruce Shannon/X

Aug 26, 2024, 20:45

Adrienne Bruce Shannon: dMMR gastroesophageal cancer treated with immunotherapy

Adrienne Bruce Shannon, CGSO fellow at Moffitt Cancer Center, shared a post on X:

“proud to present our small but mighty Moffitt Cancer Center

experience with dMMR gastroesophageal cancer treated immunotherapy now in AnnalsSurgOncology.

Happy to add to the early literature on what will be practice-changing for this disease.”

Clinical and Pathologic Response to Neoadjuvant Immunotherapy in DNA Mismatch Repair Protein‑Deficient Gastroesophageal Cancers

Authors: Adrienne B Shannon, Rutika Mehta, Shaffer R Mok, Gregory Y Lauwers, Jobelle J A R Baldonado, Jacques Fontaine, Jose M Pimiento, and Andrew J Sinnamon

Source: Adrienne Bruce Shannon/X

Adrienne B Shannon Adrienne Bruce Shannon Andrew J Sinnamon cancer dMMR gastroesophageal cancer Gregory Y Lauwers immunotherapy Jacques Fontaine Jobelle J A R Baldonado Jose M Pimiento Moffitt Cancer Center OncoDaily Oncology Rutika Mehta Shaffer R Mok

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage